Q-omics provides the consensus-scored MIR105-2 profile across patient tissues and cancer cell-line models. MIR105-2 expression is associated with patient survival in 2 of 34 cancer types, with the highest sampling consensus in BLCA. Additionally, MIR105-2 RNA expression shows 11,654 significant gene co-expression associations, with the highest sampling consensus in STAD. Together, these results highlight BLCA, and STAD as cancer lineages where MIR105-2 shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.

Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.

Premium analyses for MIR105-2 — synthetic lethality, tumor antigen, and pembrolizumab response.

View premium →

Survival associations

This table summarizes MIR105-2 survival associations across molecular data types. MIR105-2 RNA expression shows survival associations in the most cancer types (2). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.

MIR105-2 data type	Survival analysis	Lineage consensus	Lineage of highest sampling consensus
RNA	Kaplan–Meier	2	BLCA (54)	view →

This table ranks reproducible MIR105-2 RNA expression–survival associations across cancer types. High MIR105-2 expression shows unfavorable associations in BLCA and STAD. The BLCA Kaplan–Meier curve shows clear separation, with the high-expression group declining faster, consistent with the unfavorable association (log-rank p = .012). Together, the overview and detailed table identify BLCA as the clearest survival context for MIR105-2 RNA expression.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
BLCA	DFS	Tertile	All	0.152	0.625	.012	54	view →
STAD	DFS	Tertile	All	0.264	0.722	<.001	36	view →

Pink = unfavorable, green = favorable. all 2 lineages →

MIR105-2-BLCA (DFS)

Kaplan–Meier survival curve for MIR105-2 RNA expression in BLCA: high vs low expression groups.

Explore this curve interactively →

Cross-omics associations

This table shows molecular features associated with MIR105-2 in patient tissues and cancer cell lines. In patient samples, MIR105-2 shows the broadest associations at the RNA and protein expression levels, with STAD recurring as the lineage with the largest associated feature set.

Associated data type	Strength (# associated data)	Lineage of highest associated data
▼RNA
RNA	11,654	STAD (4437)	view →
Function (RNA)	4,893	STAD (4519)	view →